RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Oppenheimer: Initiating Coverage With Outperform RatingWhat I am expecting from HSM is what I get from every start-up I have invested in - a presentation for shareholders and investors that outlines management's view of how it sees its busines plan unfolding. I am not looking for precision, speculation, promises or hard facts - just management's best judgement (it can rely on the Forward-Looking disclaimer). Every start-up faces huge uncertainties and milestones beyond management's control, but that does not justify a black box investor relations approach.
vancity604 wrote: Yes, you are right, if there is no FDA approval it will be a big problem and that's what this board (and any Helius investor) has been talking about for 2+ years. Public companies (like Helius) are not allowed to speculate or make promises privately or publicly so I am not sure what you are hoping or expecting them to do.